FBXO45 and breast carcinoma: In this study, we propose that the novel DNAJB9–FBXO45 signaling axis synergistically suppresses the metastatic progression of breast cancer, and the modulation of this network is an effective therapeutic strategy against metastatic TNBC (Fig. 6).